XML 42 R31.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Stock-Based Incentive Plan (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Summary of information regarding outstanding Stock Options and Incentive Warrants and the changes during the fiscal year | The following summary presents information regarding outstanding Stock Options as of March 31, 2017, and the changes during the period:
| Number of Stock Options |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value (1) |  | Weighted Average Remaining Contractual Term (in years)
Stock Options outstanding at July 1, 2016 | 35,231 |  |  | $ | 2.19 |  |  |  |  |  |
Stock Options outstanding at March 31, 2017 | 35,231 |  |  | $ | 2.19 |  |  | $ | 204,692 |  |  | 0.4
Vested and exercisable at March 31, 2017 | 35,231 |  |  | $ | 2.19 |  |  | $ | 204,692 |  |  | 0.4
(1) Based upon the difference between the market price of our common stock on the last trading date of the period ($8.00 as of March 31, 2017) and the Stock Option exercise price of in-the-money Stock Options.
Schedule of Restricted Stock transactions | Unvested Contingent Restricted Stock awards at March 31, 2017 consisted of the following:
| Number of Contingent Restricted Shares |  | Weighted Average Grant-Date Fair Value
Performance-based awards | 39,403 |  |  | $ | 7.02 |
Market-based awards | 73,867 |  |  | 3.37 |
Unvested contingent shares at March 31, 2017 | 113,270 |  |  | $ | 4.64 |
Unvested Restricted Stock awards at March 31, 2017 consisted of the following:
| Number of Restricted Shares |  | Weighted Average Grant-Date Fair Value
Service-based awards | 219,940 |  |  | $ | 7.08 |
Performance-based awards | 54,475 |  |  | 5.67 |
Market-based awards | 119,227 |  |  | 4.97 |
Unvested Restricted Stock at March 31, 2017 | 393,642 |  |  | $ | 6.25 |
Restricted Stock |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of Restricted Stock transactions | The following table sets forth the Restricted Stock transactions for the nine months ended March 31, 2017:
| Number of Restricted Shares |  | Weighted Average Grant-Date Fair Value |  | Unamortized Compensation Expense at March 31, 2017 |  | Weighted Average Remaining Amortization Period (Years)
Unvested at July 1, 2016 | 406,848 |  |  | $ | 6.74 |  |  |  |  |
Service-based shares granted | 86,563 |  |  | 7.02 |  |  |  |  |
Performance-based shares granted | 54,475 |  |  | 5.67 |  |  |  |  |
Market-based shares granted | 54,475 |  |  | 5.44 |  |  |  |  |
Vested | (208,719 | ) |  | 7.17 |  |  |  |  |
Unvested Restricted Stock at March 31, 2017 | 393,642 |  |  | $ | 6.25 |  |  | $ | 1,923,545 |  |  | 2.2
Contingent Restricted Stock |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of Restricted Stock transactions | The following table sets forth Contingent Restricted Stock transactions for the nine months ended March 31, 2017:
| Number of Contingent Restricted Shares |  | Weighted Average Grant-Date Fair Value |  | Unamortized Compensation Expense at March 31, 2017 (1) |  | Weighted Average Remaining Amortization Period (Years)
Unvested at July 1, 2016 | 91,172 |  |  | $ | 5.21 |  |  |  |  |
Performance-based awards granted | 27,237 |  |  | 5.67 |  |  |  |  |
Market-based awards granted | 27,237 |  |  | 3.42 |  |  |  |  |
Vested | (32,376 | ) |  | 6.09 |  |  |  |  |
Unvested contingent shares at March 31, 2017 | 113,270 |  |  | $ | 4.64 |  |  | $ | 149,015 |  |  | 2.2
(1) Excludes $276,702 of potential future compensation expense for contingent performance-based awards for which vesting is not considered probable at this time for accounting purposes.

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=epm_ContingentRestrictedStockGrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |